Today is World Brain Day, and this year’s theme is Brain Health and Disability. Professor Gavin Giovannoni heads up the ‘MS Brain Health’ initiative. He’s raising awareness of the importance of brain health to help create a better future for people with MS and their families.
Everyone’s experience of MS is different. People have different symptoms. Some have more relapses or their MS progresses faster. Recent research suggests these differences are influenced by more things than we thought.
Over 2,800,000 people live with MS around the world. And vital research is happening in lots of different countries. Our Director of Research and External Affairs, Dr Sarah Rawlings, tells us about some of the latest happenings on the world MS stage.
Professor Klaus Schmierer leads research into treatments during the diagnostic phase all the way through to advanced MS. We spoke to Klaus to find out why it’s so important for people with MS to be given the choice of disease modifying therapy at every stage of their journey.
PhD student Hannah Morris-Bankole and psychologist Dr Laura Allen both live with relapsing remitting MS. They met for the first time and discussed how different therapy styles could be beneficial for people with MS at different times.
Professor Alan Thompson is consultant neurologist at University College London, and past scientific chair of the International Progressive MS Alliance. He’s been researching progressive MS for 40 years. We asked him what’s changed and what’s coming next.
Dr Prince Nwaubani is a psychiatrist, who recently passed his PhD at Brighton and Sussex Medical School. During his PhD, Prince used MRI to investigate the link between brain inflammation and depression in MS.
Dr Eleanor Doman is a mathematician, who’s now turning her attention to MS research. We’ve committed to raise funds for her new fellowship project. She tells us how she’s going to use maths to better understand the effects of disease modifying therapies (DMTs) during pregnancy.